VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Marsh & McLennan Companies, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Marsh & McLennan Companies, Inc.
MMC · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Marsh & McLennan Companies, Inc.'s moat claims, evidence, and risks.
View MMC analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 65 / 100 for Marsh & McLennan Companies, Inc.).
- Segment focus: Marsh & McLennan Companies, Inc. has 2 segments (62.8% in Risk and Insurance Services); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Marsh & McLennan Companies, Inc. has 5 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Marsh & McLennan Companies, Inc.
Risk and Insurance Services
Insurance brokerage, risk advisory, and reinsurance brokerage/services
Global
Enterprises, public entities, associations, and individuals (via broker/agent channels)
Intermediary + advisor (insurance/reinsurance market intermediary)
62.8%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Marsh & McLennan Companies, Inc. strengths
Sanofi strengths
Segment mix
Marsh & McLennan Companies, Inc. segments
Full profile >Risk and Insurance Services
Oligopoly
Consulting
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.